Computational Screening of Roxithromycin against the SARS-CoV-۲ (COVID-۱۹) Coronavirus Receptors by Molecular Docking
محل انتشار: نشریه پیشرفته شیمی، دوره: 7، شماره: 4
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 30
فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_AJCS-7-4_010
تاریخ نمایه سازی: 29 اردیبهشت 1403
چکیده مقاله:
Coronavirus, which is one of the viruses that caused severe effects, started in ۲۰۱۹; many deaths all over the world have been recorded. It is a virus that causes cough, shortness of breath, hyperthermia, and acute respiratory syndrome, followed by shortness of breath and death. Despite the creation of several vaccines that enable us to control the Coronavirus, we still do not have an effective medicine to treat it; our aim is to find out using molecular docking a drug with good activity against COVID-۱۹. In this study, we used the GOLD program, which is one of the simulation programs, and we examined several compounds for their extent of association with the enzymes of the protease, baby-like protease, etc. The result is that roxithromycin may be highly effective for treating the coronavirus and contains high binding rates, and the compound TT, where the binding rate reached ۹۷%. In this study, we have estimated the binding affinity for Papain-like protease and RNA-dependent RNA polymerases of SARS-CoV-۲ as the control molecule, and our result was that roxithromycin had the highest binding affinity. Our study concluded that after conducting molecular docking against ۳ enzymes, Mpro, PLpro, and RdRp, Roxithromycin showed promising docking results. Combating the novel coronavirus with roxithromycin alone or with other medication could be possible.
کلیدواژه ها:
نویسندگان
Dhiaa Abdulkader
Department of Pharmacy, Al-Esraa University College, Baghdad, Iraq
Mazen Jwaid
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq
Yasir F. Muhsin
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq
Fatimah Tarkan
Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq
Dhuha Shihab
Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq
Hany Al-hussaniy
Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :